M2613
Tools
Actions
General
Print/export
In other projects
Appearance
From Wikipedia, the free encyclopedia
This is the current revision of this page, as edited by Marbletan (talk | contribs) at 13:52, 26 March 2024. The present address (URL) is a permanent link to this version.
(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)
Chemical compound
Clinical data | |
---|---|
Other names | M-2613; Methoxyethoxy-triphenylbromoethylene |
Drug class | Nonsteroidal estrogen |
Identifiers | |
| |
CAS Number | |
Chemical and physical data | |
Formula | C23H21BrO2 |
Molar mass | 409.323 g·mol−1 |
M2613 is a nonsteroidal estrogen derived from triphenylbromoethylene which was studied for the treatment of breast cancer in women in the 1940s, but was never marketed.[1][2]
See also
[edit]References
[edit]- ^ Walpole AL, Paterson E (October 1949). "Synthetic oestrogens in mammary cancer". Lancet. 2 (6583): 783–6. doi:10.1016/s0140-6736(49)91370-7. PMID 15391512.
- ^ Jordan VC (February 2015). "The new biology of estrogen-induced apoptosis applied to treat and prevent breast cancer". Endocr. Relat. Cancer. 22 (1): R1–31. doi:10.1530/ERC-14-0448. PMC 4494663. PMID 25339261.
This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it. |
Retrieved from "https://en.wikipedia.org/w/index.php?title=M2613&oldid=1215670513"
Hidden categories:
- Articles with short description
- Short description matches Wikidata
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs missing an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- All stub articles